The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors
Key facts
- Who runs it
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 20 Apr 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Observational
- Treatments tested
- cataract surgery
- Record updated
- 3 June 2026
Who can take part
- Age
- 50 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age ≥ 50 years and ≤ 90 years
- Diagnosis of unilateral/bilateral age-related cataract
- Nuclear grade ≥2 in LOCSIII classification
- Scheduled for cataract phacoemulsification combined with intraocular lens implantation
- Pupil size ≥6mm after dilation
- Corneal endothelial cell count ≥1500 cells/mm²
Who cannot take part
- Other ocular factors that may complicate the surgery (such as small pupil, shallow anterior chamber)
- Diagnosis of severe systemic disease (e.g., severe hypertension or Alzheimer's disease)
- History of ocular trauma or surgery
- Presence of other ocular diseases (such as glaucoma, diabetic retinopathy, or high myopia)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 50 and 90 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to evaluate the location of phacoemulsification tip measured by intraoperative OCT during cataract surgeries and its impact on early postoperative changes of cornea and visual acuity. The main question it aims to answer is:
Read full original descriptionShow less
In patients with age-related cataracts undergoing phacoemulsification, does the location (supracapsular, iris-lens diaphragm, or endocapsular) of the phaco tip affect postoperative corneal changes and visual acuity at early postoperative stage? Eyes having phacoemulsification for cataracts will receive intraoperative OCT imaging to evaluate the location of the phaco tip during surgery, and corneal changes and visual acuity will be measured postoperatively.
The group in the trial
- Phacoemulsification
Treatment: cataract surgery
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07550907, who can take part
- Record updated
- 3 June 2026